AR

Akshay Rajendra Bansode

Active Director Director DIN 10807617
DIN 10807617 First appointment Oct 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Akshay Rajendra Bansode

Data last updated:

Akshay Rajendra Bansode is a Director at Medihype Pharma Private Limited (since 2024). The company operates in Paper.

DIN 10807617
Primary Designation Director
Industry Paper
First Appointment 14 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medihype Pharma Private Limited U21001PN2024PTC234953
Director14 Oct 20242024Active

Board colleagues of Akshay Rajendra Bansode

NameDINCompanyDesignation
Shivaji Hanumant Salunkhe10807618Medihype Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medihype Pharma Private Limited
Premium access

Shareholding and investment profile for Akshay Rajendra Bansode

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akshay Rajendra Bansode

Akshay Rajendra Bansode currently holds 1 directorship: Medihype Pharma Private Limited (Director, since 14 Oct 2024).

Akshay Rajendra Bansode was first appointed on 14 Oct 2024 as Director at Medihype Pharma Private Limited.

The current boards of Akshay Rajendra Bansode's companies include Shivaji Hanumant Salunkhe (Medihype Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available